Close

Clovis Oncology (CLVS) PT Lowered to $26 at RBC Capital Aug 2, 2019 06:41AM
Clovis Oncology (CLVS) PT Lowered to $29 at RBC Capital May 8, 2019 06:48AM
Clovis Oncology (CLVS) PT Raised to $33 at RBC Capital Feb 27, 2019 06:48AM
Pre-Open Movers 12/03: (TSRO) (GBT) (NBEV) Higher; (OCUL) (BLUE) (GSK) Lower (more...) Dec 3, 2018 09:25AM
Clovis Oncology (CLVS) PT Cut by 74% At RBC Oct 31, 2018 09:02AM


Oct 31, 2018 07:14AM Clovis Oncology (CLVS) PT Slashed 74% to $19 at RBC Capital
Oct 19, 2018 09:22AM Pre-Open Movers 10/19: (AVXL) (PYPL) (PG) Higher; (MACK) (OZK) (AKTS) Lower (more...)
Oct 19, 2018 07:54AM Clovis Oncology (CLVS) Could Trade Up $8-$16 on TRITON2 44% ORR - RBC
Jun 11, 2018 06:52AM Clovis Oncology (CLVS) PT Lowered to $73 at RBC Capital
May 9, 2018 08:18AM Clovis Oncology (CLVS) PT Raised to $74 at RBC Capital
Feb 22, 2018 04:21AM RBC Capital Upgrades Clovis Oncology (CLVS) to Outperform
Sep 14, 2017 04:25PM RBC Capital Starts Clovis Oncology (CLVS) at Sector Perform
Oct 25, 2016 10:10AM Notable Analyst Rating Changes 10/25: (MKC) (FE) (CHK) Upgraded; (VFC) (ARIA) (OCN) Downgraded
Nov 16, 2015 01:34PM Buy Immunogen (IMGN) on Clovis-Related Sell-Off, RBC Capital Says